BusinessSANUWAVE Announces First Shipments of the dermaPACE System in the U.S. MarketBy Nasdaq OMXMar 2, 2018, 2:01 PM UTC
BusinessOrigin™ Announces First 50 Patients Randomized, and Full Site Activation in Phase IIb Dose-Ranging Study for Diabetic Foot UlcersBy Nasdaq OMXJun 1, 2017, 1:06 PM UTC
